644 filings
Page 15 of 33
8-K
retqdg0ju4ol0ywfy
10 Mar 21
AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:49am
424B5
onai7
9 Mar 21
Prospectus supplement for primary offering
5:29pm
8-K
48pl04h583opoudyy4c
25 Feb 21
AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors
8:17am
424B3
ehfdf4y3gmakwtyw
17 Feb 21
Prospectus supplement
9:01am
EFFECT
udpxw4lu2bracblxh1
17 Feb 21
Notice of effectiveness
12:15am
8-K
ki75ewik7e 0uh6gdu
16 Feb 21
Other Events
8:01am
CORRESP
td3zvzdc
12 Feb 21
Correspondence with SEC
12:00am
SC 13D/A
yuh77paqom
10 Feb 21
AzurRx BioPharma / Ross Edmund Burke Jr. ownership change
9:54am
UPLOAD
ueagyx
8 Feb 21
Letter from SEC
12:00am
424B3
6f44e
22 Jan 21
Prospectus supplement
9:03am
EFFECT
cfo8qdc 171
22 Jan 21
Notice of effectiveness
12:15am
DEFA14A
alp2zhny 5a1s
20 Jan 21
Additional proxy soliciting materials
4:30pm
CORRESP
t5pz6wj4k67a uu
19 Jan 21
Correspondence with SEC
12:00am
UPLOAD
j05pdhuf4sc6q
19 Jan 21
Letter from SEC
12:00am
8-K/A
791f485msdjkvlxq
13 Jan 21
Financial Statements and Exhibits
5:29pm